It's personalized medicine's time in the spotlight as it has garnered support both from the State of California and the White House, writes the San Diego Union-Tribune. While it notes that this support hasn't come with large amounts of funding, it has given the field "a stamp of approval, indicating that this was the direction healthcare would take."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.